Imipramine on ER+ve and Triple Negative Breast Cancer

NCT03122444 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Imipramine

Sponsor

The University of Texas Health Science Center at San Antonio